https://www.selleckchem.com/pr....oducts/Gefitinib.htm
RESULTS Outcomes at the main and satellite EDs, respectively, were as follows 1-year patient capture rates were 64.6% and 64.5%; 9.9% and 4.4% of patients agreed to GC/CT testing, and of those, the provider ordered testing for 73% and 72%. CONCLUSIONS Implementation of this computerized screening tool embedded in the clinical workflow resulted in patient capture rates of almost two-thirds and clinician CDS acceptance rates 70% with limited patient agreement to testing. This screening tool is a promising method for confidential GC/
Like
Comment
Share
